Literature DB >> 9379047

Reversal reaction in borderline leprosy is associated with a polarized shift to type 1-like Mycobacterium leprae T cell reactivity in lesional skin: a follow-up study.

C E Verhagen1, E A Wierenga, A A Buffing, M A Chand, W R Faber, P K Das.   

Abstract

Borderline leprosy patients often undergo acute changes in immune reactivity that manifest as reversal reaction (RR) in the course of the disease. RR is associated with an exacerbated local delayed-type cellular immune response to Mycobacterium leprae and is responsible for severe tissue damage. We investigated whether RR episodes are associated with a change in T cell subsets in the lesional skin with regard to their cytokine secretion profiles. M. leprae-responsive T cell lines and thereafter T cell clones (TCC) were generated from the lesional skin of seven untreated borderline leprosy patients (with or without RR) and again from three of these patients experiencing RR during treatment. The phenotypes of the M. leprae-responsive TCC were either CD4+, CD8+, CD4-/CD8+/TCR gammadelta+, or CD4-/CD8-/TCR gammadelta+, although most of them were CD4+. Regardless of the clinical status of the untreated patients, a major subset of the M. leprae-responsive TCC was type 0-like and produced both IFN-gamma and IL-4. Interestingly, in all three patients who experienced a (re)occurrence of RR during treatment after the first analysis, a clear shift to polarized IFN-gamma production by the M. leprae-responsive TCC (type 1-like) was observed. This shift in T cell subsets was also reflected in the observed decrease in serum IgG and IgM levels of the same patients during RR. These finding indicate that CD4+ M. leprae-responsive T cells with a polarized type 1-like phenotype might be responsible for the immune-mediated tissue damage occurring during RR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379047

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Antigen-specific B-cell unresponsiveness induced by chronic Mycobacterium avium subsp. paratuberculosis infection of cattle.

Authors:  W R Waters; J R Stabel; R E Sacco; J A Harp; B A Pesch; M J Wannemuehler
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Complement activation in leprosy: a retrospective study shows elevated circulating terminal complement complex in reactional leprosy.

Authors:  N Bahia El Idrissi; S Hakobyan; V Ramaglia; A Geluk; B Paul Morgan; P Kumar Das; F Baas
Journal:  Clin Exp Immunol       Date:  2016-03-31       Impact factor: 4.330

3.  Functional characterization of a T-cell receptor BV6+ T-cell clone derived from a leprosy lesion.

Authors:  Shereen Sabet; Maria-Teresa Ochoa; Peter A Sieling; Thomas H Rea; Robert L Modlin
Journal:  Immunology       Date:  2006-11-28       Impact factor: 7.397

4.  Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment.

Authors:  D Little; S Khanolkar-Young; A Coulthart; S Suneetha; D N Lockwood
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor-alpha.

Authors:  M O Hernandez; I Neves; J S Sales; D S Carvalho; E N Sarno; E P Sampaio
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

6.  Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions.

Authors:  David M Scollard; Meher V Chaduvula; Alejandra Martinez; Natalie Fowlkes; Indira Nath; Barbara M Stryjewska; Michael T Kearney; Diana L Williams
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

Review 7.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

8.  High expression of myeloid-related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy.

Authors:  Cord H Sunderkötter; Jane Tomimori-Yamashita; Verena Nix; Solange M Maeda; Anca Sindrilaru; Mario Mariano; Clemens Sorg; Johannes Roth
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

9.  Role of CD8(+) T cells in triggering reversal reaction in HIV/leprosy patients.

Authors:  Ariane Leite de Oliveira; Thaís Porto Amadeu; Andressa Cristina de França Gomes; Vinícius Martins Menezes; José Augusto da Costa Nery; Roberta Olmo Pinheiro; Euzenir Nunes Sarno
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

10.  Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions.

Authors:  A Iyer; M Hatta; R Usman; S Luiten; L Oskam; W Faber; A Geluk; P Das
Journal:  Clin Exp Immunol       Date:  2007-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.